Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$1.64 - $3.3 $26,282 - $52,885
-16,026 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$2.13 - $3.24 $2,402 - $3,654
-1,128 Reduced 6.58%
16,026 $46,000
Q4 2021

Feb 11, 2022

SELL
$2.85 - $6.58 $1,464 - $3,382
-514 Reduced 2.91%
17,154 $52,000
Q3 2021

Nov 12, 2021

SELL
$6.63 - $9.39 $1,558 - $2,206
-235 Reduced 1.31%
17,668 $124,000
Q2 2021

Aug 13, 2021

SELL
$8.98 - $11.6 $709 - $916
-79 Reduced 0.44%
17,903 $164,000
Q1 2021

May 07, 2021

BUY
$9.38 - $13.63 $450 - $654
48 Added 0.27%
17,982 $175,000
Q4 2020

Feb 12, 2021

SELL
$7.78 - $12.13 $2,567 - $4,002
-330 Reduced 1.81%
17,934 $184,000
Q3 2020

Nov 04, 2020

SELL
$9.5 - $11.14 $3,952 - $4,634
-416 Reduced 2.23%
18,264 $184,000
Q2 2020

Aug 12, 2020

BUY
$7.01 - $13.24 $3,294 - $6,222
470 Added 2.58%
18,680 $195,000
Q1 2020

May 04, 2020

SELL
$6.28 - $14.57 $6,606 - $15,327
-1,052 Reduced 5.46%
18,210 $154,000
Q4 2019

Feb 05, 2020

SELL
$6.5 - $10.73 $1,053 - $1,738
-162 Reduced 0.83%
19,262 $169,000
Q3 2019

Nov 08, 2019

SELL
$8.75 - $12.85 $1,181 - $1,734
-135 Reduced 0.69%
19,424 $209,000
Q2 2019

Aug 13, 2019

BUY
$12.3 - $35.76 $12,177 - $35,402
990 Added 5.33%
19,559 $249,000
Q1 2019

May 06, 2019

SELL
$20.77 - $42.37 $12,524 - $25,549
-603 Reduced 3.15%
18,569 $720,000
Q4 2018

Feb 13, 2019

SELL
$20.07 - $46.7 $2,950 - $6,864
-147 Reduced 0.76%
19,172 $390,000
Q3 2018

Nov 09, 2018

BUY
$41.2 - $59.85 $14,337 - $20,827
348 Added 1.83%
19,319 $886,000
Q2 2018

Aug 08, 2018

BUY
$48.3 - $68.25 $15,794 - $22,317
327 Added 1.75%
18,971 $1.12 Million
Q1 2018

May 07, 2018

SELL
$59.7 - $99.25 $42,327 - $70,368
-709 Reduced 3.66%
18,644 $1.27 Million
Q4 2017

Feb 09, 2018

BUY
$93.85 - $132.45 $8,540 - $12,052
91 Added 0.47%
19,353 $1.91 Million
Q3 2017

Nov 09, 2017

BUY
$72.0 - $119.75 $1.39 Million - $2.31 Million
19,262
19,262 $2.31 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $128M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.